PDS Biotechnology Corporation
PDS Biotechnology Corporation scores highest on Nitro (70) and lowest on Price (0). Its PosiPenta is 37.17 out of 100, weaker than most similar companies.
On the Penta Grid this week, PDS Biotechnology Corporation is Grid #625 of 836 in the Healthcare sector in United States, and Grid #3,133 of 3,999 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| PDS Biotechnology Corporation | 37.17 | 0 | 56 | 70 | 8 | 51 |
| Rani Therapeutics Holdings, Inc. | 34.15 | 26 | 44 | 16 | 36 | 49 |
| Atara Biotherapeutics, Inc. | 55.33 | 0 | 67 | 53 | 93 | 63 |
| Inovio Pharmaceuticals, Inc. | 26.91 | 2 | 55 | 40 | 9 | 29 |
| Pulmonx Corporation | 41.72 | 29 | 40 | 63 | 23 | 53 |
| Tenaya Therapeutics, Inc. | 33.72 | 37 | 50 | 18 | 41 | 23 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -1.77 |
| P/B ratio | -22.88 |
EEarnings
| Trailing EPS | ₹-60.62 |
| Forward EPS | ₹-32.68 |
NNitro
| Price | 107.03 |
| 52-week high | 169.54 |
| 52-week low | 18.47 |
| Fall from 52-week high | 36.9% |
TTorque
| Return on equity (ROE) | -543.97% |
| Debt-to-equity | 1.83 |
AAnchor
| Beta (price swings) | 1.17 |
| Market cap | ₹775 Cr |
| Insider holding | 19.11% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is PDS Biotechnology Corporation's PosiPenta score?
PDS Biotechnology Corporation's PosiPenta is 37.17 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does PDS Biotechnology Corporation stand on the Penta Grid?
On the Penta Grid this week, PDS Biotechnology Corporation is Grid #625 of 836 in the Healthcare sector in United States, and Grid #3,133 of 3,999 in United States.
Which PosiPenta pillar is strongest for PDS Biotechnology Corporation?
Nitro (momentum), with a score of 70 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for PDS Biotechnology Corporation?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has PDS Biotechnology Corporation's PosiPenta changed since last week?
Yes, it fell 0.13 points, from 37.30 to 37.17.
PositoAI is for research and education only and is not investment advice.